Atiprimod (SKandF 106615), a novel macrophage targeting agent, enhances alveolar macrophage candidacidal activity and is not immunosuppresive in candida-infected mice

Azaspiranes are novel macrophage-targeting agents with activity in preclinical animal models of autoimmune disease and transplantation. The purpose of this work was to determine the effects of atiprimod (SKandF 106615), an azaspirane being developed for the treatment of rheumatoid arthritis, on rat...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	International journal of immunopharmacology 1999-04, Vol.21 (3), p.161-176
Hauptverfasser:	Badger, Alison M., Handler, Jeffrey A., Genell, Caroline A., Herzyk, Danuta, Gore, Elizabeth, Polsky, Rodd, Webb, Lee, Bugelski, Peter J.
Format:	Artikel
Sprache:	eng
Schlagworte:	Antibiotics. Antiinfectious agents. Antiparasitic agents Antifungal agents Biological and medical sciences Medical sciences Pharmacology. Drug treatments
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!